Hussein A. Elkousy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hussein A. Elkousy has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
Gary M. Gartsman
12 shared publications- Thomas Bradley Edwards
Fondren Orthopedic Group, Texas Orthopedic Hospital, Houston, TX, USA
11 shared publications T. Bradley Edwards
Fondren Orthopedic Research Institute, Fondren Orthopedic Group, Texas Orthopedic Hospital, Houston, TX, USA
8 shared publications- Brent Joseph Morris
Fondren Orthopedic Group, Texas Orthopedic Hospital, Houston, TX, USA
6 shared publications Daniel P. O’cOnnor
5 shared publicationsDaniel P. O'COnnor
Laboratory of Integrated Physiology, University of Houston, Houston, TX, USA
4 shared publications
Latest Publications
- Open Access
- 26 March 2026
- Published by Elsevier in JSES International
- Vol. 10 (4) , 101701
What are the most disruptive publications in shoulder surgery?
- 26 March 2026
- Published by Elsevier in JSES International
- Vol. 10 (4) , 101701
Open AccessWhat are the most disruptive publications in shoulder surgery?
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Orthopedics
- Vol. 2026 (1)
Endoscopic Management of Calcific Tendinopathy in the Proximal Hamstring: Two Case Reports
This report presents two cases of previously undocumented proximal hamstring calcific tendinopathy, diagnosed and treated with endoscopic management. A 54‐year‐old woman with a 50% partial‐thickness tear and a 72‐year‐old woman with a 90% tear and knee pathology underwent endoscopic debridement and tendon repair, achieving symptom relief. Neither patient had a preoperative diagnosis of calcific tendinopathy, emphasizing MRI limitations. These cases suggest that calcific tendinopathy of the proximal hamstring may be underrecognized and that endoscopic management offers direct visualization, effective debridement, and minimally invasive repair with low morbidity. Endoscopic evaluation should be considered for patients with persistent hamstring pain despite conservative treatment.
- 1 January 2026
- Published by Wiley in Case Reports in Orthopedics
- Vol. 2026 (1)
Open AccessEndoscopic Management of Calcific Tendinopathy in the Proximal Hamstring: Two Case Reports
This report presents two cases of previously undocumented proximal hamstring calcific tendinopathy, diagnosed and treated with endoscopic management. A 54‐year‐old woman with a 50% partial‐thickness tear and a 72‐year‐old woman with a 90% tear and knee pathology underwent endoscopic debridement and tendon repair, achieving symptom relief. Neither patient had a preoperative diagnosis of calcific tendinopathy, emphasizing MRI limitations. These cases suggest that calcific tendinopathy of the proximal hamstring may be underrecognized and that endoscopic management offers direct visualization, effective debridement, and minimally invasive repair with low morbidity. Endoscopic evaluation should be considered for patients with persistent hamstring pain despite conservative treatment.
- Open Access
- 23 May 2025
- Published by Elsevier in JSES International
- Vol. 9 (5) , 1437-1442
Long-term outcomes of the Latarjet procedure in a North American population
- 23 May 2025
- Published by Elsevier in JSES International
- Vol. 9 (5) , 1437-1442
Open AccessLong-term outcomes of the Latarjet procedure in a North American population
- 1 April 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (4) , 875-883
Patient satisfaction and clinical outcomes of reverse shoulder arthroplasty: a minimum of 10 years’ follow-up
- 1 April 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 31 (4) , 875-883
Patient satisfaction and clinical outcomes of reverse shoulder arthroplasty: a minimum of 10 years’ follow-up
- Open Access
- 13 January 2022
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 2 (2) , 186-189
Adverse events after mRNA vaccine administration from a busy orthopedic practice: a series of four cases
- 13 January 2022
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 2 (2) , 186-189
Open AccessAdverse events after mRNA vaccine administration from a busy orthopedic practice: a series of four cases
- 1 April 2020
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 28 (7) , 287-292
Lower Socioeconomic Status Is Associated With Worse Preoperative Function, Pain, and Increased Opioid Use in Patients With Primary Glenohumeral Osteoarthritis
Background: Numerous studies have identified differences in patient-reported outcome scores and complication rates based on various measures of socioeconomic status (SES); however, there is limited information regarding the role of SES in the shoulder arthroplasty cohort. The purpose of this study was to characterize the role of SES in patients undergoing primary anatomic total shoulder arthroplasty (TSA) for primary glenohumeral osteoarthritis (OA). Methods: We identified 1,045 patients who had primary TSA done for OA in a prospective shoulder arthroplasty registry, and 982 patients met inclusion criteria. We prospectively assessed patient demographics, comorbidities, patient-reported outcome scores, range of motion, and preoperative opioid use. Each patient was assigned to a quartile according to the Area Deprivation Index using their home address as a measure of SES. Results: The most disadvantaged patients (lower SES) reported to our center with a higher body mass index and higher rates of preoperative opioid use and diabetes. Patients in the most disadvantaged quartile reported more preoperative pain (Constant—Pain and American Shoulder and Elbow Surgeons [ASES]—Pain) and lower function (Constant—ADL, Constant—Total, and ASES). Multivariate regression identified that male patients and advanced age at surgery had better reported ASES pain scores, while preoperative opioid use, chronic back pain, and the most disadvantaged quartile were associated with worse ASES pain scores. Conclusion: Lower SES correlates with worse preoperative function and pain in patients undergoing anatomic TSA for primary glenohumeral OA. Providers should be cognizant of the potential impact of SES when evaluating quality metrics for patients with primary glenohumeral OA. Level of Evidence: Level 3, cross-sectional study.
- 1 April 2020
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 28 (7) , 287-292
Lower Socioeconomic Status Is Associated With Worse Preoperative Function, Pain, and Increased Opioid Use in Patients With Primary Glenohumeral Osteoarthritis
Background: Numerous studies have identified differences in patient-reported outcome scores and complication rates based on various measures of socioeconomic status (SES); however, there is limited information regarding the role of SES in the shoulder arthroplasty cohort. The purpose of this study was to characterize the role of SES in patients undergoing primary anatomic total shoulder arthroplasty (TSA) for primary glenohumeral osteoarthritis (OA). Methods: We identified 1,045 patients who had primary TSA done for OA in a prospective shoulder arthroplasty registry, and 982 patients met inclusion criteria. We prospectively assessed patient demographics, comorbidities, patient-reported outcome scores, range of motion, and preoperative opioid use. Each patient was assigned to a quartile according to the Area Deprivation Index using their home address as a measure of SES. Results: The most disadvantaged patients (lower SES) reported to our center with a higher body mass index and higher rates of preoperative opioid use and diabetes. Patients in the most disadvantaged quartile reported more preoperative pain (Constant—Pain and American Shoulder and Elbow Surgeons [ASES]—Pain) and lower function (Constant—ADL, Constant—Total, and ASES). Multivariate regression identified that male patients and advanced age at surgery had better reported ASES pain scores, while preoperative opioid use, chronic back pain, and the most disadvantaged quartile were associated with worse ASES pain scores. Conclusion: Lower SES correlates with worse preoperative function and pain in patients undergoing anatomic TSA for primary glenohumeral OA. Providers should be cognizant of the potential impact of SES when evaluating quality metrics for patients with primary glenohumeral OA. Level of Evidence: Level 3, cross-sectional study.
- 1 December 2017
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 26 (12) , 2078-2085
Radiographic and clinical comparison of pegged and keeled glenoid components using modern cementing techniques: midterm results of a prospective randomized study
- 1 December 2017
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 26 (12) , 2078-2085
Radiographic and clinical comparison of pegged and keeled glenoid components using modern cementing techniques: midterm results of a prospective randomized study
- 22 June 2016
- Vol. 45 (4) , E180-6
Obesity Has Minimal Impact on Short-Term Functional Scores After Reverse Shoulder Arthroplasty for Rotator Cuff Tear Arthropathy.
The potential adverse effect of body mass index (BMI) on shoulder function scores after reverse shoulder arthroplasty (RSA) has not been investigated. We conducted a study to examine outcomes of RSA performed for rotator cuff tear arthropathy (RCTA) across BMI categories (normal weight, overweight, obese). We hypothesized that, compared with normal-weight patients, obese patients would have worse shoulder function scores, worse mobility, and more complications. Using a prospective shoulder arthroplasty registry, we identified 77 primary RSAs performed for RCTA with minimum 2-year follow-up. Thirty-four patients had normal weight (BMI 30 kg/m2). Shoulder function scores, mobility, and satisfaction were evaluated before surgery and at final follow-up. The 3 BMI groups were not significantly different on demographic factors, preoperative shoulder function scores, or preoperative mobility (P > .05). For each group, shoulder function scores and mobility significantly improved between the preoperative and final follow-up assessments (P < .001). Patient satisfaction was similar between groups (P = .967). Improved shoulder function scores, mobility, and patient satisfaction can be expected after RSA for RCTA in patients regardless of BMI.
- 22 June 2016
- Vol. 45 (4) , E180-6
Obesity Has Minimal Impact on Short-Term Functional Scores After Reverse Shoulder Arthroplasty for Rotator Cuff Tear Arthropathy.
The potential adverse effect of body mass index (BMI) on shoulder function scores after reverse shoulder arthroplasty (RSA) has not been investigated. We conducted a study to examine outcomes of RSA performed for rotator cuff tear arthropathy (RCTA) across BMI categories (normal weight, overweight, obese). We hypothesized that, compared with normal-weight patients, obese patients would have worse shoulder function scores, worse mobility, and more complications. Using a prospective shoulder arthroplasty registry, we identified 77 primary RSAs performed for RCTA with minimum 2-year follow-up. Thirty-four patients had normal weight (BMI 30 kg/m2). Shoulder function scores, mobility, and satisfaction were evaluated before surgery and at final follow-up. The 3 BMI groups were not significantly different on demographic factors, preoperative shoulder function scores, or preoperative mobility (P > .05). For each group, shoulder function scores and mobility significantly improved between the preoperative and final follow-up assessments (P < .001). Patient satisfaction was similar between groups (P = .967). Improved shoulder function scores, mobility, and patient satisfaction can be expected after RSA for RCTA in patients regardless of BMI.
- 1 August 2015
- Published by SLACK, Inc.
- Vol. 38 (8) , e701-e707
Reverse Shoulder Arthroplasty for Management of Postinfectious Arthropathy With Rotator Cuff Deficiency
Feature Article Free Brent J. Morris, MD; Wame N. Waggenspack Jr, MD; Mitzi S. Laughlin, PhD; Hussein A. Elkousy, MD; Gary M. Gartsman, MD; T. Bradley Edwards, MD Treatment of patients with rotator cuff deficiency and arthritis in the setting of a prior glenohumeral infection (postinfectious arthropathy) is complex, with little evidence to guide treatment. The current authors present their approach to management of these patients and clinical outcomes after reverse shoulder arthroplasty (RSA). All primary RSAs performed for postinfectious arthropathy and rotator cuff deficiency with native glenohumeral joints were identified in a prospective shoulder arthroplasty registry. Eight patients with a minimum of 2-year follow-up were included in the analysis. Clinical outcomes, including the Constant score, the American Shoulder and Elbow Surgeons (ASES) score, the Western Ontario Osteoarthritis Shoulder (WOOS) index, the Single Assessment Numeric Evaluation (SANE) score, and range of motion measurements, were assessed preoperatively and at final follow-up. At an average follow-up of 4.4 years, no patient had a clinically detectable recurrence of infection. Significant improvements were noted in all outcome scores from preoperative evaluation to final follow-up after RSA, including Constant score (P=.003), ASES score (P<.001), WOOS index (P=.002), SANE score (P=.025), forward flexion (P<.001), abduction (P<.001), and external rotation (P=.020). Seven of 8 patients reported they were satisfied or very satisfied at final follow-up. Reverse shoulder arthroplasty can be performed in patients without significant medical comorbidities in the setting of postinfectious arthropathy and rotator cuff deficiency with a low risk of recurrence of infection. Significant clinical improvements were noted at short-term follow-up. [Orthopedics. 2015; 38(8):e701–e707.] The authors are from Lexington Clinic Orthopedics (BJM), Shoulder Center of Kentucky, Lexington, Kentucky; the Department of Orthopaedic Surgery (WNW), Louisiana State University Health Sciences Center, New Orleans, Louisiana; and the Department of Health and Human Performance (MSL), University of Houston, and Fondren Orthopedic Group (HAE, GMG, TBE), Texas Orthopedic Hospital, Houston, Texas. Drs Morris, Waggenspack, Laughlin, Elkousy, and Gartsman have no relevant financial relationships to disclose. Dr Edwards is a paid consultant for Tornier, Inc, Kinamed, Inc, Shoulder Options, Inc, and OrthoHelix Surgical Designs, Inc. Correspondence should be addressed to: Brent J. Morris, MD, Lexington Clinic Orthopedics, Shoulder Center of Kentucky, 700 Bob-O-Link Dr, Lexington, KY 40504 ( brent.joseph.morris@gmail.com). Rotator cuff deficiency and arthritis in the setting of a prior glenohumeral infection (postinfectious arthropathy) is a devastating problem often associated with severely diminished function, debilitating pain, and few treatment options. Shoulder arthroplasty has been reported to provide improved pain and function in patients with postinfectious glenohumeral arthritis1; however, anatomic shoulder arthroplasty relies on a functional rotator cuff for optimal results. Reverse shoulder arthroplasty (RSA) can be used as an alternative treatment in the setting of postinfectious arthropathy with rotator cuff deficiency. Reverse shoulder arthroplasty is classically used for glenohumeral arthritis with a deficient rotator cuff,2,3 but promising results have been described for other pathologies.4–10 Reverse shoulder arthroplasty for postinfectious arthropathy has been reported in a single series of patients11; however, the majority of the shoulders (17 of 22) reported had infection in the setting of a prior hemiarthroplasty, whereas only 5 shoulders had an intact, native glenohumeral joint. The purpose of the current study was to present the authors’ approach to management and clinical outcomes in patients following RSA for postinfectious arthropathy with rotator cuff deficiency and a native glenohumeral joint. The primary hypothesis was that patients with a history of postinfectious arthropathy would have improved clinical outcome scores following RSA. The secondary hypothesis was that patients with a history of postinfectious arthropathy would have a low risk of recurrent infection following RSA when following the authors’ treatment algorithm. The authors identified all primary RSAs completed for postinfectious arthropathy from 2004 to 2011 in a prospectively collected shoulder arthroplasty registry. Eleven patients were identified, and 3 patients were excluded due to inadequate follow-up (less than 2-year follow-up). Eight patients with a minimum of 2-year follow-up were included in the analysis. Six of the 8 patients had a history of deep infection following rotator cuff repair, and 1 patient had an infection following open reduction and internal fixation (ORIF) of a proximal humeral fracture. One patient did not have prior surgery, and the etiology of infection was unknown. All patients had native glenohumeral joints, and none had a prior history of hemiarthroplasty or total shoulder arthroplasty. All patients had positive cultures or clear documentation of infection treated at outside facilities. All cases were performed at a single, high-volume shoulder arthroplasty center by a single surgeon (T.B.E.). All patients had rotator cuff deficiency and end-stage arthritis documented with preoperative computed tomography arthrogram or magnetic resonance imaging and noted intraoperatively. Seven of the 8 patients had massive irreparable supraspinatus, infraspinatus, and subscapularis tears, and 1 patient had massive irreparable...
- 1 August 2015
- Published by SLACK, Inc.
- Vol. 38 (8) , e701-e707
Reverse Shoulder Arthroplasty for Management of Postinfectious Arthropathy With Rotator Cuff Deficiency
Feature Article Free Brent J. Morris, MD; Wame N. Waggenspack Jr, MD; Mitzi S. Laughlin, PhD; Hussein A. Elkousy, MD; Gary M. Gartsman, MD; T. Bradley Edwards, MD Treatment of patients with rotator cuff deficiency and arthritis in the setting of a prior glenohumeral infection (postinfectious arthropathy) is complex, with little evidence to guide treatment. The current authors present their approach to management of these patients and clinical outcomes after reverse shoulder arthroplasty (RSA). All primary RSAs performed for postinfectious arthropathy and rotator cuff deficiency with native glenohumeral joints were identified in a prospective shoulder arthroplasty registry. Eight patients with a minimum of 2-year follow-up were included in the analysis. Clinical outcomes, including the Constant score, the American Shoulder and Elbow Surgeons (ASES) score, the Western Ontario Osteoarthritis Shoulder (WOOS) index, the Single Assessment Numeric Evaluation (SANE) score, and range of motion measurements, were assessed preoperatively and at final follow-up. At an average follow-up of 4.4 years, no patient had a clinically detectable recurrence of infection. Significant improvements were noted in all outcome scores from preoperative evaluation to final follow-up after RSA, including Constant score (P=.003), ASES score (P<.001), WOOS index (P=.002), SANE score (P=.025), forward flexion (P<.001), abduction (P<.001), and external rotation (P=.020). Seven of 8 patients reported they were satisfied or very satisfied at final follow-up. Reverse shoulder arthroplasty can be performed in patients without significant medical comorbidities in the setting of postinfectious arthropathy and rotator cuff deficiency with a low risk of recurrence of infection. Significant clinical improvements were noted at short-term follow-up. [Orthopedics. 2015; 38(8):e701–e707.] The authors are from Lexington Clinic Orthopedics (BJM), Shoulder Center of Kentucky, Lexington, Kentucky; the Department of Orthopaedic Surgery (WNW), Louisiana State University Health Sciences Center, New Orleans, Louisiana; and the Department of Health and Human Performance (MSL), University of Houston, and Fondren Orthopedic Group (HAE, GMG, TBE), Texas Orthopedic Hospital, Houston, Texas. Drs Morris, Waggenspack, Laughlin, Elkousy, and Gartsman have no relevant financial relationships to disclose. Dr Edwards is a paid consultant for Tornier, Inc, Kinamed, Inc, Shoulder Options, Inc, and OrthoHelix Surgical Designs, Inc. Correspondence should be addressed to: Brent J. Morris, MD, Lexington Clinic Orthopedics, Shoulder Center of Kentucky, 700 Bob-O-Link Dr, Lexington, KY 40504 ( brent.joseph.morris@gmail.com). Rotator cuff deficiency and arthritis in the setting of a prior glenohumeral infection (postinfectious arthropathy) is a devastating problem often associated with severely diminished function, debilitating pain, and few treatment options. Shoulder arthroplasty has been reported to provide improved pain and function in patients with postinfectious glenohumeral arthritis1; however, anatomic shoulder arthroplasty relies on a functional rotator cuff for optimal results. Reverse shoulder arthroplasty (RSA) can be used as an alternative treatment in the setting of postinfectious arthropathy with rotator cuff deficiency. Reverse shoulder arthroplasty is classically used for glenohumeral arthritis with a deficient rotator cuff,2,3 but promising results have been described for other pathologies.4–10 Reverse shoulder arthroplasty for postinfectious arthropathy has been reported in a single series of patients11; however, the majority of the shoulders (17 of 22) reported had infection in the setting of a prior hemiarthroplasty, whereas only 5 shoulders had an intact, native glenohumeral joint. The purpose of the current study was to present the authors’ approach to management and clinical outcomes in patients following RSA for postinfectious arthropathy with rotator cuff deficiency and a native glenohumeral joint. The primary hypothesis was that patients with a history of postinfectious arthropathy would have improved clinical outcome scores following RSA. The secondary hypothesis was that patients with a history of postinfectious arthropathy would have a low risk of recurrent infection following RSA when following the authors’ treatment algorithm. The authors identified all primary RSAs completed for postinfectious arthropathy from 2004 to 2011 in a prospectively collected shoulder arthroplasty registry. Eleven patients were identified, and 3 patients were excluded due to inadequate follow-up (less than 2-year follow-up). Eight patients with a minimum of 2-year follow-up were included in the analysis. Six of the 8 patients had a history of deep infection following rotator cuff repair, and 1 patient had an infection following open reduction and internal fixation (ORIF) of a proximal humeral fracture. One patient did not have prior surgery, and the etiology of infection was unknown. All patients had native glenohumeral joints, and none had a prior history of hemiarthroplasty or total shoulder arthroplasty. All patients had positive cultures or clear documentation of infection treated at outside facilities. All cases were performed at a single, high-volume shoulder arthroplasty center by a single surgeon (T.B.E.). All patients had rotator cuff deficiency and end-stage arthritis documented with preoperative computed tomography arthrogram or magnetic resonance imaging and noted intraoperatively. Seven of the 8 patients had massive irreparable supraspinatus, infraspinatus, and subscapularis tears, and 1 patient had massive irreparable...